Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of p53 in transcriptional repression of SVCT2.
Kim EH, Koh DI, Ryu YS, Park SS, Hong SW, Moon JH, Shin JS, Kim MJ, Kim DY, Hong JK, Jeong HR, Yun H, Shin JY, Kim J, Park YS, Kim DM, Jin DH. Kim EH, et al. Among authors: kim dy, kim dm, kim j, kim mj. Mol Biol Rep. 2021 Feb;48(2):1651-1658. doi: 10.1007/s11033-021-06179-2. Epub 2021 Feb 12. Mol Biol Rep. 2021. PMID: 33580460
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH. Moon JH, et al. Among authors: kim eh, kim tw, kim dy, kim js, kim dm, kim sm, kim je, kim j, kim mj, kim k. Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4. Br J Cancer. 2019. PMID: 30944457 Free PMC article.
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.
Kim DM, Kim MJ, Moon JH, Lee EY, Hong JK, Lee S, Koh DI, Ryu YS, Kim SM, Jung SA, Shin JS, Kim J, Park YS, Hong SW, Lee SH, Jung J, Park SS, Kim DY, Kim EH, Jeong HR, Gong JH, Kim J, Chan Kim S, Yu HN, Ki SY, Kim TW, Jin DH. Kim DM, et al. Among authors: kim eh, kim tw, kim dy, kim sm, kim j, kim mj. Biochem Biophys Res Commun. 2020 Jun 18;527(1):305-310. doi: 10.1016/j.bbrc.2020.04.095. Epub 2020 May 11. Biochem Biophys Res Commun. 2020. PMID: 32446385
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells.
Hong SW, Shin JS, Moon JH, Jung SA, Koh DI, Ryu Y, Park YS, Kim DY, Park SS, Hong JK, Kim EH, Kim MJ, Jeong HR, Bae IH, Ahn YG, Suh KH, Cho IJ, Kang JS, Hong YS, Lee JS, Jin DH, Kim TW. Hong SW, et al. Among authors: kim eh, kim tw, kim dy, kim mj. Invest New Drugs. 2020 Dec;38(6):1696-1706. doi: 10.1007/s10637-020-00956-9. Epub 2020 May 27. Invest New Drugs. 2020. PMID: 32462369
Mutation SVCT2 promotes cell proliferation, invasion and migration in colorectal cancer.
Park SS, Ryu YS, Koh DI, Hong SW, Moon JH, Shin JS, Kim MJ, Kim DY, Hong JK, Kim EH, Jeong HR, Park YS, Kim J, Kim DM, Yun H, Shin JY, Jin DH. Park SS, et al. Among authors: kim eh, kim dy, kim dm, kim j, kim mj. J Cancer. 2021 Jul 6;12(18):5385-5393. doi: 10.7150/jca.57463. eCollection 2021. J Cancer. 2021. PMID: 34405001 Free PMC article.
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.
Hong JK, Kim DY, Shin JS, Ryu YS, Moon JH, Koh DI, Lee S, Lee J, Lee WJ, Lee EY, Jung SA, Kim SC, Yu HN, Kim MJ, Hong SW, Park SS, Jung J, Kim SM, Kim EH, Jeong HR, Gong JH, Kim J, Kim TW, Jin DH. Hong JK, et al. Among authors: kim sc, kim eh, kim tw, kim dy, kim sm, kim j, kim mj. Anticancer Res. 2022 Apr;42(4):1813-1819. doi: 10.21873/anticanres.15657. Anticancer Res. 2022. PMID: 35346999
2,118 results